arrow
R

Rong Tao

fudan university shanghai cancer center
H指数:28
被引数:2,616

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study

更正:泽布替尼联合R-CHOP用于具有特定基因突变且既往未治疗的弥漫性大B细胞淋巴瘤的二期研究

2026-11-050
OA
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Epcoritamab、lenalidomide和rituximab与lenalidomide和rituximab治疗复发或难治性滤泡性淋巴瘤的比较(EPCORE FL-1):一项全球性、开放标签、随机、III期临床试验

2025-12-070
OAAI
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma

循环肿瘤DNA甲基化标志物在结外自然杀伤/T细胞淋巴瘤中的诊断性能及预后价值

2023-02-018
OAAI